» Articles » PMID: 30093764

Evaluation of Manual Mycobacterium Growth Indicator Tube for Isolation and Susceptibility Testing of for Implementation in Low and Medium Volume Laboratories

Overview
Specialty General Medicine
Date 2018 Aug 11
PMID 30093764
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Manual Mycobacterium growth indicator tube (MGIT) was evaluated for isolation and drug susceptibility testing (DST) of (MTB) for its implementation in laboratories with low and medium volume.

Methods: 1018 consecutive clinical specimens were processed using manual MGIT and conventional Lowenstein-Jensen (LJ) culture. Results obtained for culture positivity were analyzed taking combined reference of positivity by either solid or liquid culture. All positive cultures were identified and DST to first line drugs was performed by manual MGIT and 1% proportional method on LJ media. Performance of manual MGIT for DST was compared to conventional DST on LJ media.

Result: Of the total 220 culture positive samples 93.9% were isolated in MGIT while 75.7% in LJ taking combined reference of positivity by either solid or liquid culture. Turn around time for isolation of MTB was significantly less for MGIT as compared to LJ. There was good agreement between manual MGIT and 1% proportional method on LJ media for DST to first line drugs. Turnaround time from inoculation to DST results for smear positive and smear negative cases using manual MGIT was 20.2 and 30.1 days respectively. The total cost for isolation, identification and DST in manual MGIT for smear positive and smear negative cases was INR 2350 and INR 2700 respectively.

Conclusion: It is feasible to implement manual MGIT in low to medium volume laboratory that already has experience with culture provided adequate biosafety measures and appropriate training of laboratory staff are taken care of.

Citing Articles

Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia.

Seid A, Girma Y, Abebe A, Dereb E, Kassa M, Berhane N Infect Drug Resist. 2023; 16:3829-3845.

PMID: 37346368 PMC: 10281285. DOI: 10.2147/IDR.S412951.


Man and Microbe: Fraternizing with the frenemy.

Subramanian S Med J Armed Forces India. 2019; 75(1):6-7.

PMID: 30705471 PMC: 6349669. DOI: 10.1016/j.mjafi.2018.12.017.


Tuberculosis diagnosis in resource limited settings.

Sen S Med J Armed Forces India. 2018; 74(3):211-212.

PMID: 30093761 PMC: 6081278. DOI: 10.1016/j.mjafi.2018.06.003.

References
1.
Shinnick T, Iademarco M, Ridderhof J . National plan for reliable tuberculosis laboratory services using a systems approach. Recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. MMWR Recomm Rep. 2005; 54(RR-6):1-12. View

2.
Stall N, Rubin T, Michael J, Mathai D, Abraham O, Mathews P . Does solid culture for tuberculosis influence clinical decision making in India?. Int J Tuberc Lung Dis. 2011; 15(5):641-6. DOI: 10.5588/ijtld.10.0195. View

3.
Hanna B, Ebrahimzadeh A, Elliott L, Morgan M, Novak S, Rusch-Gerdes S . Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol. 1999; 37(3):748-52. PMC: 84542. DOI: 10.1128/JCM.37.3.748-752.1999. View

4.
Goloubeva V, Lecocq M, Lassowsky P, Matthys F, Portaels F, Bastian I . Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J Clin Microbiol. 2001; 39(4):1501-5. PMC: 87960. DOI: 10.1128/JCM.39.4.1501-1505.2001. View

5.
Rodrigues C, Shenai S, Sadani M, Sukhadia N, Jani M, Ajbani K . Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J Med Microbiol. 2009; 27(3):217-21. DOI: 10.4103/0255-0857.53203. View